The Dermatological Products Market is expected to register a CAGR of 12.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, Others); Drug Type (Prescription-Based Drugs, Over-the-Counter Drugs); Gender Type (Female, Male). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Dermatological Products Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Dermatological Products Market Segmentation
Disease- Acne
- Dermatitis
- Psoriasis
- Skin Cancer
- Rosacea
- Alopecia
- Prescription-Based Drugs
- Over-the-Counter Drugs
- Female
- Male
Strategic Insights
Dermatological Products Market Growth Drivers- Rising Incidence of Skin Disorders: The increasing prevalence of dermatological conditions such as acne, eczema, psoriasis, and skin cancer is a significant driver for the dermatological products market. Skin disorders, particularly acne, affect a large portion of the global population, both in adolescents and adults, creating a substantial demand for treatment products. Additionally, the incidence of skin diseases like eczema and psoriasis is rising due to factors such as environmental pollution, poor lifestyle choices, and genetics. As the demand for effective treatments grows, the dermatological products market is expected to expand rapidly. Products such as topical treatments, oral medications, and biologic therapies for conditions like psoriasis are gaining traction, helping to improve patient outcomes. Market size forecasts indicate that skin-related diseases will continue to contribute to the growth of the dermatological products market, as consumers seek more advanced solutions.
- Advancements in Dermatological Research: Ongoing advancements in dermatological research are driving the development of more effective, safe, and targeted skincare treatments. Research into molecular biology and skin physiology has enabled the creation of more sophisticated products tailored to specific skin concerns. New active ingredients, improved formulations, and cutting-edge technologies such as nanotechnology are enhancing the efficacy of dermatological products. Additionally, with increasing understanding of how certain conditions impact skin health, targeted therapies for chronic conditions like acne, rosacea, and skin aging are becoming more personalized. These advancements are expected to fuel the market size of dermatological products, as consumers and healthcare professionals alike opt for treatments that provide faster and longer-lasting results.
- Increasing Consumer Awareness of Skin Health: As people become more aware of the importance of skincare and the potential risks of neglecting skin health, there has been a notable surge in the demand for dermatological products. Consumer education regarding the long-term effects of sun exposure, pollution, and aging has increased the adoption of skincare products for protection, prevention, and treatment. With a greater focus on both aesthetic concerns and medical skincare, there is an increasing trend of consumers seeking professional dermatological products, which has led to an overall expansion in the market. The growing interest in self-care, combined with the influence of social media and beauty influencers, has also contributed to the rising demand for dermatological products, including anti-aging solutions, moisturizers, and sunscreens.
- Rise in Demand for Natural and Organic Skincare: Consumers are increasingly turning toward natural and organic skincare products due to growing concerns about the potential long-term effects of chemicals and synthetic ingredients. With rising awareness regarding the risks of harsh chemicals in skincare, more individuals are opting for dermatological products that are free from parabens, sulfates, and artificial fragrances. This trend is driving the development of plant-based and all-natural formulations that cater to consumers seeking gentle yet effective skincare solutions. Market forecasts indicate that natural and organic skincare products will continue to gain market share, as they are perceived to be safer and more environmentally friendly. As a result, companies are incorporating botanical extracts, essential oils, and other organic ingredients into their dermatological products to cater to this growing segment.
- Advancement in Personalized Skincare: Personalization is becoming a significant trend in the dermatological products market. Advances in technology, particularly in areas such as artificial intelligence (AI) and genetic testing, are enabling brands to offer more personalized skincare solutions. By analyzing an individual’s skin type, genetic makeup, and lifestyle, personalized skincare products can be tailored to provide the most effective results. This trend is gaining momentum as consumers seek more targeted treatments that address their unique skin needs. Personalized skincare products may include custom-formulated creams, serums, and cleansers, and even treatments for specific conditions like acne or aging. With the rise of at-home skincare devices and DNA-based skin tests, this trend is set to continue driving innovation and market growth in dermatology.
- Increasing Popularity of Anti-Aging Products: The global aging population, coupled with increased demand for youth-preserving treatments, has made anti-aging skincare one of the most lucrative segments in the dermatological products market. Products designed to reduce wrinkles, fine lines, and sagging skin are in high demand, especially among middle-aged and older consumers. The effectiveness of ingredients like retinoids, peptides, hyaluronic acid, and antioxidants in combating skin aging has led to the growing popularity of anti-aging skincare products. Moreover, with consumers increasingly seeking non-invasive cosmetic procedures, there is a rising demand for dermatological products that can complement these treatments. Anti-aging skincare products are projected to remain a dominant trend in the dermatological products market, with new formulations continuously entering the market to meet the evolving needs of consumers.
- Expanding Market for Over-the-Counter (OTC) Dermatological Products: The growing trend toward self-medication and increased consumer access to healthcare information is opening up substantial opportunities in the over-the-counter (OTC) dermatological products market. OTC products for common skin conditions such as acne, eczema, and dry skin are seeing widespread adoption. Consumers are increasingly turning to OTC options for managing mild to moderate conditions, which has created a thriving market for products like medicated creams, ointments, sunscreens, and moisturizers. This shift toward self-care is driving demand for convenient, accessible, and affordable skincare solutions. As more consumers seek effective treatments without the need for prescriptions, the OTC dermatological products market is expected to grow significantly, presenting opportunities for brands to expand their product offerings.
- Innovation in Sunscreen and Sun Protection Products: Sunscreen and sun protection products are a critical segment within the dermatological products market, as consumers become more aware of the harmful effects of UV radiation on skin health. As a result, there is an increasing demand for high-quality, broad-spectrum sunscreens that offer both protection and added skincare benefits. Innovations in sunscreen formulations, such as mineral-based sunscreens and products with added antioxidants or anti-aging properties, are expected to drive the growth of this segment. Additionally, the rising awareness of skin cancer and the importance of UV protection is leading to increased adoption of sunscreen products globally. The growing focus on sun protection as part of daily skincare routines represents a significant growth opportunity within the dermatological products market.
- Integration of Dermatological Products with Lifestyle and Wellness: The integration of dermatological products with overall wellness and lifestyle is a growing opportunity for brands. As consumers increasingly view skincare as part of their broader health and wellness routines, dermatological products are being marketed alongside other wellness-related items such as dietary supplements, fitness products, and stress management tools. Brands are beginning to emphasize holistic skincare, integrating dermatological products with other lifestyle products aimed at improving overall well-being. For example, supplements that support skin health, along with skincare treatments designed to work in harmony with a balanced lifestyle, are becoming more popular. This trend is likely to expand the reach of dermatological products, particularly as consumer interest in wellness continues to rise globally.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Dermatological Products Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Dermatological Products Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Dermatological Products Market is estimated to witness a CAGR of 12.5% from 2025 to 2031.
The major factors driving the Dermatological Products Market are Rising Incidence of Skin Disorders, Advancements in Dermatological Research, Increasing Consumer Awareness of Skin Health.
Future trends in the Dermatological Products Market are Rise in Demand for Natural and Organic Skincare, Advancement in Personalized Skincare, Increasing Popularity of Anti-Aging Products.
Some of the players operating in the market are Bayer AG, Johnson & Johnson, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca, Galderma S.A., Amgen Inc., AbbVie Inc., Merck KGaA
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dermatological Products Market - By Disease
1.3.2 Dermatological Products Market - By Drug Type
1.3.3 Dermatological Products Market - By Gender Type
1.3.4 Dermatological Products Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DERMATOLOGICAL PRODUCTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DERMATOLOGICAL PRODUCTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DERMATOLOGICAL PRODUCTS MARKET - GLOBAL MARKET ANALYSIS
6.1. DERMATOLOGICAL PRODUCTS - GLOBAL MARKET OVERVIEW
6.2. DERMATOLOGICAL PRODUCTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DERMATOLOGICAL PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
7.1. OVERVIEW
7.2. DISEASE MARKET FORECASTS AND ANALYSIS
7.3. ACNE
7.3.1. Overview
7.3.2. Acne Market Forecast and Analysis
7.4. DERMATITIS
7.4.1. Overview
7.4.2. Dermatitis Market Forecast and Analysis
7.5. PSORIASIS
7.5.1. Overview
7.5.2. Psoriasis Market Forecast and Analysis
7.6. SKIN CANCER
7.6.1. Overview
7.6.2. Skin Cancer Market Forecast and Analysis
7.7. ROSACEA
7.7.1. Overview
7.7.2. Rosacea Market Forecast and Analysis
7.8. ALOPECIA
7.8.1. Overview
7.8.2. Alopecia Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. DERMATOLOGICAL PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. PRESCRIPTION-BASED DRUGS
8.3.1. Overview
8.3.2. Prescription-Based Drugs Market Forecast and Analysis
8.4. OVER-THE-COUNTER DRUGS
8.4.1. Overview
8.4.2. Over-the-Counter Drugs Market Forecast and Analysis
9. DERMATOLOGICAL PRODUCTS MARKET - REVENUE AND FORECASTS TO 2028 - GENDER TYPE
9.1. OVERVIEW
9.2. GENDER TYPE MARKET FORECASTS AND ANALYSIS
9.3. FEMALE
9.3.1. Overview
9.3.2. Female Market Forecast and Analysis
9.4. MALE
9.4.1. Overview
9.4.2. Male Market Forecast and Analysis
10. DERMATOLOGICAL PRODUCTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Dermatological Products Market Overview
10.1.2 North America Dermatological Products Market Forecasts and Analysis
10.1.3 North America Dermatological Products Market Forecasts and Analysis - By Disease
10.1.4 North America Dermatological Products Market Forecasts and Analysis - By Drug Type
10.1.5 North America Dermatological Products Market Forecasts and Analysis - By Gender Type
10.1.6 North America Dermatological Products Market Forecasts and Analysis - By Countries
10.1.6.1 United States Dermatological Products Market
10.1.6.1.1 United States Dermatological Products Market by Disease
10.1.6.1.2 United States Dermatological Products Market by Drug Type
10.1.6.1.3 United States Dermatological Products Market by Gender Type
10.1.6.2 Canada Dermatological Products Market
10.1.6.2.1 Canada Dermatological Products Market by Disease
10.1.6.2.2 Canada Dermatological Products Market by Drug Type
10.1.6.2.3 Canada Dermatological Products Market by Gender Type
10.1.6.3 Mexico Dermatological Products Market
10.1.6.3.1 Mexico Dermatological Products Market by Disease
10.1.6.3.2 Mexico Dermatological Products Market by Drug Type
10.1.6.3.3 Mexico Dermatological Products Market by Gender Type
10.2. EUROPE
10.2.1 Europe Dermatological Products Market Overview
10.2.2 Europe Dermatological Products Market Forecasts and Analysis
10.2.3 Europe Dermatological Products Market Forecasts and Analysis - By Disease
10.2.4 Europe Dermatological Products Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Dermatological Products Market Forecasts and Analysis - By Gender Type
10.2.6 Europe Dermatological Products Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Dermatological Products Market
10.2.6.1.1 Germany Dermatological Products Market by Disease
10.2.6.1.2 Germany Dermatological Products Market by Drug Type
10.2.6.1.3 Germany Dermatological Products Market by Gender Type
10.2.6.2 France Dermatological Products Market
10.2.6.2.1 France Dermatological Products Market by Disease
10.2.6.2.2 France Dermatological Products Market by Drug Type
10.2.6.2.3 France Dermatological Products Market by Gender Type
10.2.6.3 Italy Dermatological Products Market
10.2.6.3.1 Italy Dermatological Products Market by Disease
10.2.6.3.2 Italy Dermatological Products Market by Drug Type
10.2.6.3.3 Italy Dermatological Products Market by Gender Type
10.2.6.4 Spain Dermatological Products Market
10.2.6.4.1 Spain Dermatological Products Market by Disease
10.2.6.4.2 Spain Dermatological Products Market by Drug Type
10.2.6.4.3 Spain Dermatological Products Market by Gender Type
10.2.6.5 United Kingdom Dermatological Products Market
10.2.6.5.1 United Kingdom Dermatological Products Market by Disease
10.2.6.5.2 United Kingdom Dermatological Products Market by Drug Type
10.2.6.5.3 United Kingdom Dermatological Products Market by Gender Type
10.2.6.6 Rest of Europe Dermatological Products Market
10.2.6.6.1 Rest of Europe Dermatological Products Market by Disease
10.2.6.6.2 Rest of Europe Dermatological Products Market by Drug Type
10.2.6.6.3 Rest of Europe Dermatological Products Market by Gender Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Dermatological Products Market Overview
10.3.2 Asia-Pacific Dermatological Products Market Forecasts and Analysis
10.3.3 Asia-Pacific Dermatological Products Market Forecasts and Analysis - By Disease
10.3.4 Asia-Pacific Dermatological Products Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Dermatological Products Market Forecasts and Analysis - By Gender Type
10.3.6 Asia-Pacific Dermatological Products Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Dermatological Products Market
10.3.6.1.1 Australia Dermatological Products Market by Disease
10.3.6.1.2 Australia Dermatological Products Market by Drug Type
10.3.6.1.3 Australia Dermatological Products Market by Gender Type
10.3.6.2 China Dermatological Products Market
10.3.6.2.1 China Dermatological Products Market by Disease
10.3.6.2.2 China Dermatological Products Market by Drug Type
10.3.6.2.3 China Dermatological Products Market by Gender Type
10.3.6.3 India Dermatological Products Market
10.3.6.3.1 India Dermatological Products Market by Disease
10.3.6.3.2 India Dermatological Products Market by Drug Type
10.3.6.3.3 India Dermatological Products Market by Gender Type
10.3.6.4 Japan Dermatological Products Market
10.3.6.4.1 Japan Dermatological Products Market by Disease
10.3.6.4.2 Japan Dermatological Products Market by Drug Type
10.3.6.4.3 Japan Dermatological Products Market by Gender Type
10.3.6.5 South Korea Dermatological Products Market
10.3.6.5.1 South Korea Dermatological Products Market by Disease
10.3.6.5.2 South Korea Dermatological Products Market by Drug Type
10.3.6.5.3 South Korea Dermatological Products Market by Gender Type
10.3.6.6 Rest of Asia-Pacific Dermatological Products Market
10.3.6.6.1 Rest of Asia-Pacific Dermatological Products Market by Disease
10.3.6.6.2 Rest of Asia-Pacific Dermatological Products Market by Drug Type
10.3.6.6.3 Rest of Asia-Pacific Dermatological Products Market by Gender Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Dermatological Products Market Overview
10.4.2 Middle East and Africa Dermatological Products Market Forecasts and Analysis
10.4.3 Middle East and Africa Dermatological Products Market Forecasts and Analysis - By Disease
10.4.4 Middle East and Africa Dermatological Products Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Dermatological Products Market Forecasts and Analysis - By Gender Type
10.4.6 Middle East and Africa Dermatological Products Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Dermatological Products Market
10.4.6.1.1 South Africa Dermatological Products Market by Disease
10.4.6.1.2 South Africa Dermatological Products Market by Drug Type
10.4.6.1.3 South Africa Dermatological Products Market by Gender Type
10.4.6.2 Saudi Arabia Dermatological Products Market
10.4.6.2.1 Saudi Arabia Dermatological Products Market by Disease
10.4.6.2.2 Saudi Arabia Dermatological Products Market by Drug Type
10.4.6.2.3 Saudi Arabia Dermatological Products Market by Gender Type
10.4.6.3 U.A.E Dermatological Products Market
10.4.6.3.1 U.A.E Dermatological Products Market by Disease
10.4.6.3.2 U.A.E Dermatological Products Market by Drug Type
10.4.6.3.3 U.A.E Dermatological Products Market by Gender Type
10.4.6.4 Rest of Middle East and Africa Dermatological Products Market
10.4.6.4.1 Rest of Middle East and Africa Dermatological Products Market by Disease
10.4.6.4.2 Rest of Middle East and Africa Dermatological Products Market by Drug Type
10.4.6.4.3 Rest of Middle East and Africa Dermatological Products Market by Gender Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Dermatological Products Market Overview
10.5.2 South and Central America Dermatological Products Market Forecasts and Analysis
10.5.3 South and Central America Dermatological Products Market Forecasts and Analysis - By Disease
10.5.4 South and Central America Dermatological Products Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Dermatological Products Market Forecasts and Analysis - By Gender Type
10.5.6 South and Central America Dermatological Products Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Dermatological Products Market
10.5.6.1.1 Brazil Dermatological Products Market by Disease
10.5.6.1.2 Brazil Dermatological Products Market by Drug Type
10.5.6.1.3 Brazil Dermatological Products Market by Gender Type
10.5.6.2 Argentina Dermatological Products Market
10.5.6.2.1 Argentina Dermatological Products Market by Disease
10.5.6.2.2 Argentina Dermatological Products Market by Drug Type
10.5.6.2.3 Argentina Dermatological Products Market by Gender Type
10.5.6.3 Rest of South and Central America Dermatological Products Market
10.5.6.3.1 Rest of South and Central America Dermatological Products Market by Disease
10.5.6.3.2 Rest of South and Central America Dermatological Products Market by Drug Type
10.5.6.3.3 Rest of South and Central America Dermatological Products Market by Gender Type
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DERMATOLOGICAL PRODUCTS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DERMATOLOGICAL PRODUCTS MARKET, KEY COMPANY PROFILES
13.1. BAYER AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. JOHNSON AND JOHNSON
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PFIZER INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ASTRAZENECA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GALDERMA S.A.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. AMGEN INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABBVIE INC.,
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MERCK KGAA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Bayer AG
2. Johnson & Johnson
3. Pfizer Inc.
4. Novartis AG
5. GlaxoSmithKline plc
6. AstraZeneca
7. Galderma S.A.
8. Amgen Inc.
9. AbbVie Inc.
10. Merck KGaA
11. Avon Products, Inc.
12. Shiseido Co., Ltd.
13. Ikeda Mohando Co Ltd
14. Taisho Pharmaceutical
15. Perrigo Company Plc
16. Emami Ltd.
17. Pierre Fabre SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For